Pilot engagement · suggested pathways

Start with one bounded implant decision.

Suggested pilot pathways help teams pressure-test a vendor claim, standardization decision, or high-cost ASC implant question before the decision is documented. The output is a committee-facing decision record — not a literature review.

Three suggested pathways are starting points, not an exhaustive product menu. Each pilot is bounded to one product category, claim set, or decision question — supporting an active committee timeline.

Bounded scope · 2–3 weeks · committee-facing output
Pilot output preview
Sample structure
01
Evidence map
Date-windowed inventory · direct system evidence vs design-lever evidence separated.
02
Claim-support matrix
Supported · weakly supported · not substantiated.
03
Independence profile
Authorship and funding pattern analysis.
04
Decision record
Committee-facing output with caveats, confidence ceiling, and decision options.
The result A concise evidence record your team can use to document what was reviewed, what was supported, what remained uncertain, and where the confidence ceiling sits.
Decision moments

Where independent evidence review changes the conversation.

New product request entering committee review
Claim-support and independence screen before the request advances.
Vendor packet under value-analysis review
Claim-support and independence check on the submitted evidence.
Premium-pricing claim awaiting committee approval
Whether the evidence supports the claimed level of confidence without important caveats.
Standardization, dual-source, or multisource decision
Clinical comparability review across competing systems before contract decisions are finalized.
Contract-compliance or exception discussion
Whether non-standard, premium-priced, or off-contract use is clinically defensible for the specific use case.
High-cost implant decision in an ambulatory surgery setting
ASC-specific value review: claim audit, comparability, exception rationale, and reimbursement / value context where outpatient margin pressure makes the decision sharper.

Adjacent use cases — COE network design, employer-purchaser benefit design, payer-side surgical pathway due diligence — may be supportable in a separate scope; current pilot pathways focus on the value-analysis, clinical supply chain, and ASC lanes.

Scope

One decision. One bounded engagement.

A pilot targets one of: a single vendor evidence package, a single implant system, a single provider-program evidence story, or a single defined decision question. Full implant-category reviews require a separate scope — the pilot is intentionally bounded so it can support an active decision timeline.

Pilot scope
Engagement summary
Subject
One vendor packet · system · provider-program story · or decision question
Claims under review
A defined claim set surfaced from the evidence package
Evidence window
Bounded by the decision-snapshot date
Source review
Targeted to the in-window pivotal pool
Independence screen
Authorship and funding pattern analysis
Registry signal
In-window registry check against the pivotal pool
Output
One committee- or network-facing decision record
Timeline
2–3 weeks from kickoff
Outside pilot scope

When the scope becomes a full audit.

If a prospective engagement requires any of the above, the right scope is a full category audit at a separate engagement tier.

Sample output format

A retrospective demonstration is available on request.

A sample retrospective audit format is available after a scoping call. The sample illustrates the structure of the deliverable; full source review and category-wide coverage are handled through a separately scoped engagement.

What happens next
A scoping call identifies the decision question, evidence window, audience for the output, and whether a pilot or broader audit is the right fit.

Best for active product decisions involving a vendor packet, premium-pricing claim, standardization question, exception request, or high-cost ASC implant decision.

Submit a bounded decision question Discuss a possible pilot →

Zero Prior is operated by Vetra Health Strategies LLC. Zero Prior content is not intended to be the sole or primary basis for any clinical, purchasing, procurement, regulatory, or investment decision with material consequences. Such decisions are made on the basis of independent professional judgment applied to the totality of available information; Zero Prior content is at most one input among many. Full COI & Independence Disclosure →